Richard D. Truesdell, Jr.
Lawyers
Filters
Deciphera Pharmaceuticals $135.1 million common stock offering
The common stock is listed on the Nasdaq Global Select Market
Biodesix $40 million follow-on offering
The shares are listed on the Nasdaq Global Market
Privia Health $135 million secondary offering
We advised Privia on its debut shelf takedown offering
Zoetis $1.35 billion senior notes offering
The investment-grade notes are due 2025 and 2032
Kinsale Capital Group follow-on offering
The stock is listed on the NYSE
Marsh McLennan $1 billion senior notes offering
We advised Marsh McLennan on its investment-grade notes offering
ADT $1.2 billion cash tender offer for stock
The company’s shares are traded on the NYSE
Prime Medicine $175 million IPO
The shares are listed on the Nasdaq Global Market
Valero Energy $1.25 billion cash tender offer
The company purchased certain debt securities
Alnylam Pharmaceuticals $1.035 billion convertible senior notes offering
The 1% convertible notes are due 2027